Orthopedic Devices Global Market – Forecast To 2021
Orthopedic device can be defined as medical device used to replace the damaged or misplaced bone in order to improve the function of skeleton and reduce pain due to problems associated with injury/defect. The implants are basically made out of stainless steel and titanium alloys for more durability and strength whereas now novel biomaterials like ceramics, glass and polymers are used. Revolution in the field of medical science has led to the rapid development of orthopedic devices that are invented to effectively treat orthopedic injuries and diseases like osteoporosis and osteoarthritis. These device implantation procedures require highly specialized surgeons.
Insisting innovative product designs, drift towards cost effective solutions, increase in number of outpatient procedures and adoption of advanced technologies drives the market growth whereas, high cost of implants, reimbursement issues are the major factors that restrain the market growth. The emergence of small players with highly innovative products and their designs are also creating an opportunity in the global orthopedic device market to experience a high growth rate. While the market faces major challenges due to subject of finances, geographies and technology opportunities.
The drastic advancements in the field of robotics, computer navigated surgeries, smart implants, nanotechnology, 3D printings, biologics and tissue engineering have been recognized as the future of orthopedics. Now-a-days customized implant is increasing in the market as patient demands more comfortable product fit for implantation. For instance, ConfirMIS is one the major company which develops personalized implants for knee such as iTotal G2, iDuo G2 etc.
Zimmer Biomet, Stryker, Smith and Nephew, Medtronic, Nuvasive, Depuy Synthes, Orthosensor, Integra Lifescience, Globus Medical, B.Braun and DJO global are some of the companies that play a major role in manufacturing orthopedic devices. Depuy Synthes accounts for the major orthopedic market share followed by Zimmer Biomet and Stryker. Medtronic is one of the leading companies in the market producing which produces spine implant whereas Depuy Synthes has a major market share in hip and knee implant.
Based on geography, orthopedic devices market is divided into North America, Europe, Asia-Pacific and Rest of the world. A matured region such as North America commanded with the largest market revenue. High investments in healthcare infrastructures and demand for quality services in the market propelled the market growth in this region. However, Asia-pacific region is expected to grow at the highest CAGR during the forecast period due to increased healthcare awareness, improved economic growth and increasing government funds. Significant mergers and acquisitions, collaborations, joint ventures are some of the industry trends that are playing a major role for the market growth.
Insisting innovative product designs, drift towards cost effective solutions, increase in number of outpatient procedures and adoption of advanced technologies drives the market growth whereas, high cost of implants, reimbursement issues are the major factors that restrain the market growth. The emergence of small players with highly innovative products and their designs are also creating an opportunity in the global orthopedic device market to experience a high growth rate. While the market faces major challenges due to subject of finances, geographies and technology opportunities.
The drastic advancements in the field of robotics, computer navigated surgeries, smart implants, nanotechnology, 3D printings, biologics and tissue engineering have been recognized as the future of orthopedics. Now-a-days customized implant is increasing in the market as patient demands more comfortable product fit for implantation. For instance, ConfirMIS is one the major company which develops personalized implants for knee such as iTotal G2, iDuo G2 etc.
Zimmer Biomet, Stryker, Smith and Nephew, Medtronic, Nuvasive, Depuy Synthes, Orthosensor, Integra Lifescience, Globus Medical, B.Braun and DJO global are some of the companies that play a major role in manufacturing orthopedic devices. Depuy Synthes accounts for the major orthopedic market share followed by Zimmer Biomet and Stryker. Medtronic is one of the leading companies in the market producing which produces spine implant whereas Depuy Synthes has a major market share in hip and knee implant.
Based on geography, orthopedic devices market is divided into North America, Europe, Asia-Pacific and Rest of the world. A matured region such as North America commanded with the largest market revenue. High investments in healthcare infrastructures and demand for quality services in the market propelled the market growth in this region. However, Asia-pacific region is expected to grow at the highest CAGR during the forecast period due to increased healthcare awareness, improved economic growth and increasing government funds. Significant mergers and acquisitions, collaborations, joint ventures are some of the industry trends that are playing a major role for the market growth.
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 High prevalence of osteoporosis or osteoarthritis and increase in ageing population
3.3.1.2 Increasing demand for minimally invasive surgeries
3.3.1.3 Increasing number of outpatient procedure
3.3.1.4 Increase in accidents and sports injuries
3.3.1.5 High preference for orthopedic implants
3.3.1.6 Development of robotics
3.3.1.7 Identifying lightweight implants with new materials
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of implants
3.3.2.2 Increasing pricing pressure from buyer and payer
3.3.2.3 Impact of medical device excise tax
3.3.2.4 Product recalls due to manufacturing errors
3.3.3 BURNING ISSUE
3.3.3.1 Lack of skilled orthopedic surgeon
3.3.3.2 Change in reimbursement scenario
3.3.4 CHALLENGES
3.3.4.1 High cost of sophisticated manufacturing equipment
3.3.5 WINNING IMPERATIVES
3.3.5.1 Innovation in biologics
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
3.6 IMPLANT MATERIALS & COATINGS
3.6.1 METALS
3.6.2 CERAMICS
3.6.3 BIO-GLASS
3.6.4 POLYMER
3.6.5 MEDICAL COATINGS
3.7 PATENT TRENDS
3.7.1 TECHNOLOGICAL ADVANCEMENTS
3.7.1.1 Minimally invasive surgery (MIS)
3.7.1.2 Computer navigated and robotic surgery
3.7.1.3 3D printing/additive manufacturing
3.7.1.4 Biologics and tissue engineering
3.7.1.5 Smart implants
3.7.1.6 Nanotechnology
3.8 UPCOMING TECHNOLOGIES
3.9 CUSTOM IMPLANTS
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 BARGAINING POWER OF SUPPLIERS
3.10.4 BARGAINING POWER OF BUYERS
3.10.5 RIVALRY AMONG EXISTING COMPETITORS
3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.11.1 KNEE MARKET SHARE ANALYSIS
3.11.2 HIP MARKET SHARE ANALYSIS
3.11.3 SPINE MARKET SHARE ANALYSIS
4 ORTHOPEDIC DEVICES GLOBAL MARKET, BY TYPES
4.1 INTRODUCTION
4.2 ANATOMICAL LOCATIONS
4.2.1 ELBOW
4.2.2 KNEE
4.2.3 HIP
4.2.4 SHOULDER
4.2.5 SPINE
4.2.6 FOOT AND ANKLE
4.2.7 CRANIOMAXILLOFACIAL (CMF)
4.2.8 OTHER EXTREMITIES
4.3 CONSUMABLES
4.3.1 ANCHORS
4.3.1.1 Metallic anchors
4.3.1.2 Suture anchors
4.3.2 STAPLES
4.4 TRAUMA FIXATION
4.4.1 INTERNAL FIXATION DEVICES
4.4.2 EXTERNAL FIXATION DEVICES
5 ORTHOPEDIC DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 TOTAL KNEE REPLACEMENT
5.3 TOTAL HIP REPLACEMENT
5.4 TOTAL SHOULDER REPLACEMENT
5.5 ARTHROSCOPIC SURGERY
5.6 SPINE SURGERY
5.7 ANKLE REPLACEMENT
5.8 OTHERS
6 ORTHOPEDIC DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 PRIVATE ORTHOPEDIC CLINICS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.3.1 GERMANY
7.4 ASIA PACIFIC
7.4.1 INDIA
7.5 REST OF THE WORLD
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCHES
8.3 MERGERS & ACQUISITIONS
8.4 APPROVALS
8.5 AGREEMENTS & EXPANSION
9 MAJOR PLAYER PROFILES
9.1 B.BRAUN MELSUNGEN AG
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 DEPUY SYNTHES (JOHNSON & JOHNSON)
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 DJO GLOBAL, INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 GLOBUS MEDICAL, INC.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 INTEGRA LIFESCIENCES CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MEDTRONIC, PLC
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 NUVASIVE, INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 SMITH & NEPHEW, PLC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 STRYKER CORPORATION
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 ZIMMER BIOMET HOLDINGS, INC
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 High prevalence of osteoporosis or osteoarthritis and increase in ageing population
3.3.1.2 Increasing demand for minimally invasive surgeries
3.3.1.3 Increasing number of outpatient procedure
3.3.1.4 Increase in accidents and sports injuries
3.3.1.5 High preference for orthopedic implants
3.3.1.6 Development of robotics
3.3.1.7 Identifying lightweight implants with new materials
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of implants
3.3.2.2 Increasing pricing pressure from buyer and payer
3.3.2.3 Impact of medical device excise tax
3.3.2.4 Product recalls due to manufacturing errors
3.3.3 BURNING ISSUE
3.3.3.1 Lack of skilled orthopedic surgeon
3.3.3.2 Change in reimbursement scenario
3.3.4 CHALLENGES
3.3.4.1 High cost of sophisticated manufacturing equipment
3.3.5 WINNING IMPERATIVES
3.3.5.1 Innovation in biologics
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
3.6 IMPLANT MATERIALS & COATINGS
3.6.1 METALS
3.6.2 CERAMICS
3.6.3 BIO-GLASS
3.6.4 POLYMER
3.6.5 MEDICAL COATINGS
3.7 PATENT TRENDS
3.7.1 TECHNOLOGICAL ADVANCEMENTS
3.7.1.1 Minimally invasive surgery (MIS)
3.7.1.2 Computer navigated and robotic surgery
3.7.1.3 3D printing/additive manufacturing
3.7.1.4 Biologics and tissue engineering
3.7.1.5 Smart implants
3.7.1.6 Nanotechnology
3.8 UPCOMING TECHNOLOGIES
3.9 CUSTOM IMPLANTS
3.10 PORTER’S FIVE FORCE ANALYSIS
3.10.1 THREAT OF NEW ENTRANTS
3.10.2 THREAT OF SUBSTITUTES
3.10.3 BARGAINING POWER OF SUPPLIERS
3.10.4 BARGAINING POWER OF BUYERS
3.10.5 RIVALRY AMONG EXISTING COMPETITORS
3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.11.1 KNEE MARKET SHARE ANALYSIS
3.11.2 HIP MARKET SHARE ANALYSIS
3.11.3 SPINE MARKET SHARE ANALYSIS
4 ORTHOPEDIC DEVICES GLOBAL MARKET, BY TYPES
4.1 INTRODUCTION
4.2 ANATOMICAL LOCATIONS
4.2.1 ELBOW
4.2.2 KNEE
4.2.3 HIP
4.2.4 SHOULDER
4.2.5 SPINE
4.2.6 FOOT AND ANKLE
4.2.7 CRANIOMAXILLOFACIAL (CMF)
4.2.8 OTHER EXTREMITIES
4.3 CONSUMABLES
4.3.1 ANCHORS
4.3.1.1 Metallic anchors
4.3.1.2 Suture anchors
4.3.2 STAPLES
4.4 TRAUMA FIXATION
4.4.1 INTERNAL FIXATION DEVICES
4.4.2 EXTERNAL FIXATION DEVICES
5 ORTHOPEDIC DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 TOTAL KNEE REPLACEMENT
5.3 TOTAL HIP REPLACEMENT
5.4 TOTAL SHOULDER REPLACEMENT
5.5 ARTHROSCOPIC SURGERY
5.6 SPINE SURGERY
5.7 ANKLE REPLACEMENT
5.8 OTHERS
6 ORTHOPEDIC DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 PRIVATE ORTHOPEDIC CLINICS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.3.1 GERMANY
7.4 ASIA PACIFIC
7.4.1 INDIA
7.5 REST OF THE WORLD
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCHES
8.3 MERGERS & ACQUISITIONS
8.4 APPROVALS
8.5 AGREEMENTS & EXPANSION
9 MAJOR PLAYER PROFILES
9.1 B.BRAUN MELSUNGEN AG
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 DEPUY SYNTHES (JOHNSON & JOHNSON)
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 DJO GLOBAL, INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 GLOBUS MEDICAL, INC.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 INTEGRA LIFESCIENCES CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MEDTRONIC, PLC
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 NUVASIVE, INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 SMITH & NEPHEW, PLC.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 STRYKER CORPORATION
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 ZIMMER BIOMET HOLDINGS, INC
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 2 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 3 ANATOMICAL LOCATION GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 4 ORTHOPEDIC ANATOMICAL LOCATION GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 5 GLOBAL KNEE, HIP, SPINE AND SHOULDER PROCEDURAL VOLUME DATA (2013-2021)
Table 6 ELBOW DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 7 KNEE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 8 KNEE GLOBAL PROCEDURAL VOLUME DATA (2013-2021)
Table 9 HIP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 10 HIP GLOBAL PROCEDURAL VOLUME DATA (2013-2021)
Table 11 SHOULDER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 12 SHOULDER GLOBAL PROCEDURAL VOLUME DATA (2013-2021)
Table 13 SPINE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 14 GLOBAL SPINE PROCEDURAL VOLUME DATA (2013-2021)
Table 15 FOOT AND ANKLE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 16 CRANIOMAXILLOFACIAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 17 OTHER EXTREMITIES DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 18 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 19 ORTHOPEDIC CONSUMABLES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 20 ORTHOPEDIC ANCHORS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 21 ANCHORS GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 22 METALLIC ANCHOR GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 23 SUTURE ANCHORS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 24 STAPLES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 25 TRAUMA FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 26 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY FIXATION DEVICE (2013-2021) ($MN)
Table 27 INTERNAL FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 28 EXTERNAL FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 29 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 30 TOTAL KNEE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 31 TOTAL HIP REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 32 TOTAL SHOULDER REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 33 ARTHROSCOPIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 34 SPINE SURGERY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 35 ANKLE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 36 OTHERS ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 37 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 38 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 39 PRIVATE ORTHOPEDIC CLINICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 40 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 41 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 42 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 43 NORTH AMERICAN ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 44 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 45 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 46 NORTH AMERICAN TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 47 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 48 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 49 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 50 EUROPEAN ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 51 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 52 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY END USERS, (2013-2021) ($MN)
Table 53 EUROPEAN TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 54 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 55 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 56 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 57 ASIA-PACIFIC ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 58 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 59 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY END USERS, (2013-2021) ($MN)
Table 60 ASIA-PACIFIC TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 61 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 62 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 63 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 64 ROW ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 65 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 66 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 67 ROW TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 68 NEW PRODUCT LAUNCHES (2013-2015)
Table 69 MERGERS & ACQUISTIONS (2013-2015)
Table 70 APPROVALS (2013-2015)
Table 71 AGREEMENTS & EXPANSION (2013-2015)
Table 72 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 73 B.BRAUN MELSENGEN,AG: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 74 B.BRAUN MELSENGEN,AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 75 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 76 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 77 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 78 DJO GLOBAL, INC.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 79 DJO GLOBAL, INC.: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 80 DJO GLOBAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 81 GLOBUS MEDICAL, INC.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 82 GLOBUS MEDICAL, INC.: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 83 GLOBUS MEDICAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 84 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 85 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 86 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 87 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 88 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 89 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 90 NUVASIVE, INC.: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 91 NUVASIVE, INC.: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 92 NUVASIVE, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 93 SMITH & NEPHEW, PLC: TOTAL SALES AND R&D EXPENSES, (2012-2014) ($MN)
Table 94 SMITH & NEPHEW, PLC: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 95 SMITH & NEPHEW, PLC: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 96 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 97 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 98 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 99 ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 100 ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 101 ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 1 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 2 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 3 ANATOMICAL LOCATION GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 4 ORTHOPEDIC ANATOMICAL LOCATION GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 5 GLOBAL KNEE, HIP, SPINE AND SHOULDER PROCEDURAL VOLUME DATA (2013-2021)
Table 6 ELBOW DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 7 KNEE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 8 KNEE GLOBAL PROCEDURAL VOLUME DATA (2013-2021)
Table 9 HIP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 10 HIP GLOBAL PROCEDURAL VOLUME DATA (2013-2021)
Table 11 SHOULDER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 12 SHOULDER GLOBAL PROCEDURAL VOLUME DATA (2013-2021)
Table 13 SPINE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 14 GLOBAL SPINE PROCEDURAL VOLUME DATA (2013-2021)
Table 15 FOOT AND ANKLE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 16 CRANIOMAXILLOFACIAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 17 OTHER EXTREMITIES DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 18 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 19 ORTHOPEDIC CONSUMABLES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 20 ORTHOPEDIC ANCHORS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 21 ANCHORS GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 22 METALLIC ANCHOR GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 23 SUTURE ANCHORS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 24 STAPLES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 25 TRAUMA FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 26 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY FIXATION DEVICE (2013-2021) ($MN)
Table 27 INTERNAL FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 28 EXTERNAL FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 29 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 30 TOTAL KNEE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 31 TOTAL HIP REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 32 TOTAL SHOULDER REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 33 ARTHROSCOPIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 34 SPINE SURGERY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 35 ANKLE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 36 OTHERS ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 37 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 38 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 39 PRIVATE ORTHOPEDIC CLINICS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 40 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 41 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 42 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 43 NORTH AMERICAN ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 44 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 45 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 46 NORTH AMERICAN TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 47 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 48 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 49 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 50 EUROPEAN ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 51 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 52 EUROPEAN ORTHOPEDIC DEVICES MARKET REVENUE, BY END USERS, (2013-2021) ($MN)
Table 53 EUROPEAN TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 54 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 55 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 56 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 57 ASIA-PACIFIC ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 58 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 59 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET REVENUE, BY END USERS, (2013-2021) ($MN)
Table 60 ASIA-PACIFIC TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 61 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 62 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY ANATOMICAL LOCATION, (2013-2021) ($MN)
Table 63 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY CONSUMABLES, (2013-2021) ($MN)
Table 64 ROW ANCHOR MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 65 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 66 ROW ORTHOPEDIC DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 67 ROW TRAUMA FIXATION DEVICES MARKET REVENUE, BY FIXATION, (2013-2021) ($MN)
Table 68 NEW PRODUCT LAUNCHES (2013-2015)
Table 69 MERGERS & ACQUISTIONS (2013-2015)
Table 70 APPROVALS (2013-2015)
Table 71 AGREEMENTS & EXPANSION (2013-2015)
Table 72 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 73 B.BRAUN MELSENGEN,AG: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 74 B.BRAUN MELSENGEN,AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 75 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 76 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 77 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 78 DJO GLOBAL, INC.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 79 DJO GLOBAL, INC.: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 80 DJO GLOBAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 81 GLOBUS MEDICAL, INC.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 82 GLOBUS MEDICAL, INC.: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 83 GLOBUS MEDICAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 84 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 85 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 86 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 87 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 88 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 89 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 90 NUVASIVE, INC.: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 91 NUVASIVE, INC.: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 92 NUVASIVE, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 93 SMITH & NEPHEW, PLC: TOTAL SALES AND R&D EXPENSES, (2012-2014) ($MN)
Table 94 SMITH & NEPHEW, PLC: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 95 SMITH & NEPHEW, PLC: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 96 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 97 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 98 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 99 ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 100 ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 101 ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
LIST OF FIGURES
Figure 1 GLOBAL ORTHOPEDIC DEVICES MARKET SHARE AND REVENUE, BY REGION (2013-2021)
Figure 2 RESEARCH METHODOLOGY: ORTHOPEDIC DEVICES GLOBAL MARKET
Figure 3 ORTHOPEDIC DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 ORTHOPEDIC DEVICES MARKET: FORECASTING MODEL
Figure 5 ORTHOPEDIC DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 ORTHOPEDIC DEVICES MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 ORTHOPEDIC DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2010-2015)
Figure 9 ORTHOPEDIC DEVICES MARKET: PORTER’S ANALYSIS
Figure 10 ORTHOPEDIC DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 11 KNEE ORTHOPEDIC DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 12 ORTHOPEDIC DEVICES HIP MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 13 ORTHOPEDIC DEVICES SPINE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 14 ORTHOPEDIC GLOBAL MARKET REVENUE BY ANATOMICAL LOCATION, BY TYPE (2014 V/S 2021) ($MN)
Figure 15 ORTHOPEDIC GLOBAL CONSUMABLE MARKET, BY TYPE (2013-2021) ($MN)
Figure 16 ORTHOPEDIC TRAUMA FIXATION DEVICES GLOBAL REVENUE, BY FIXATION DEVICE (2014 V’S 2021) ($MN)
Figure 17 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2014 V’S 2021) ($MN)
Figure 18 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY END USERS (2014 V’S 2021) ($MN)
Figure 19 GLOBAL ORTHOPEDIC DEVICES MARKET REVENUE, BY REGION (2013-2021) ($MN)
Figure 20 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 21 EUROPEAN ORTHOPEDIC DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 22 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 23 ROW OPHTHMOLOGY DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 24 KEY GROWTH STRATEGIES, (2013-2015)
Figure 25 SWOT: B.BRAUN MELSUNGEN, AG
Figure 26 SWOT: JOHNSON & JOHNSON (DEPUY SYNTHES)
Figure 27 SWOT: DJO GLOBAL, INC.
Figure 28 SWOT: GLOBUS MEDICAL, INC.
Figure 29 SWOT: INTEGRA LIFESCIENCES CORPORATION
Figure 30 SWOT: MEDTRONIC, PLC
Figure 31 SWOT: NUVASIVE, INC.
Figure 32 SWOT: SMITH & NEPHEW, PLC.
Figure 33 SWOT: STRYKER CORPORATION
Figure 34 SWOT: ZIMMER BIOMET HOLDINGS, INC
Figure 1 GLOBAL ORTHOPEDIC DEVICES MARKET SHARE AND REVENUE, BY REGION (2013-2021)
Figure 2 RESEARCH METHODOLOGY: ORTHOPEDIC DEVICES GLOBAL MARKET
Figure 3 ORTHOPEDIC DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 ORTHOPEDIC DEVICES MARKET: FORECASTING MODEL
Figure 5 ORTHOPEDIC DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 ORTHOPEDIC DEVICES MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 ORTHOPEDIC DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2010-2015)
Figure 9 ORTHOPEDIC DEVICES MARKET: PORTER’S ANALYSIS
Figure 10 ORTHOPEDIC DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 11 KNEE ORTHOPEDIC DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 12 ORTHOPEDIC DEVICES HIP MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 13 ORTHOPEDIC DEVICES SPINE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 14 ORTHOPEDIC GLOBAL MARKET REVENUE BY ANATOMICAL LOCATION, BY TYPE (2014 V/S 2021) ($MN)
Figure 15 ORTHOPEDIC GLOBAL CONSUMABLE MARKET, BY TYPE (2013-2021) ($MN)
Figure 16 ORTHOPEDIC TRAUMA FIXATION DEVICES GLOBAL REVENUE, BY FIXATION DEVICE (2014 V’S 2021) ($MN)
Figure 17 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2014 V’S 2021) ($MN)
Figure 18 ORTHOPEDIC DEVICES GLOBAL MARKET REVENUE, BY END USERS (2014 V’S 2021) ($MN)
Figure 19 GLOBAL ORTHOPEDIC DEVICES MARKET REVENUE, BY REGION (2013-2021) ($MN)
Figure 20 NORTH AMERICAN ORTHOPEDIC DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 21 EUROPEAN ORTHOPEDIC DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 22 ASIA-PACIFIC ORTHOPEDIC DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 23 ROW OPHTHMOLOGY DEVICES MARKET SIZE, BY APPLICATION, END-USER & FIXATION OUTLOOK, (2014 V’S 2021)
Figure 24 KEY GROWTH STRATEGIES, (2013-2015)
Figure 25 SWOT: B.BRAUN MELSUNGEN, AG
Figure 26 SWOT: JOHNSON & JOHNSON (DEPUY SYNTHES)
Figure 27 SWOT: DJO GLOBAL, INC.
Figure 28 SWOT: GLOBUS MEDICAL, INC.
Figure 29 SWOT: INTEGRA LIFESCIENCES CORPORATION
Figure 30 SWOT: MEDTRONIC, PLC
Figure 31 SWOT: NUVASIVE, INC.
Figure 32 SWOT: SMITH & NEPHEW, PLC.
Figure 33 SWOT: STRYKER CORPORATION
Figure 34 SWOT: ZIMMER BIOMET HOLDINGS, INC
